Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Trial Profile

Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine conjugate PPV 23
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 18 Nov 2014 Status changed from not yet recruiting to recruiting, according to ClinialTrials.gov record.
    • 31 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top